Impaired Autophagy in CD11b + Dendritic Cells Expands CD4 + Regulatory T Cells and Limits Atherosclerosis in Mice
Open Access
- 8 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 125 (11) , 1019-1034
Abstract
Rationale: Atherosclerosis is a chronic inflammatory disease. Recent studies have shown that dysfunctional autophagy in endothelial cells, smooth muscle cells, and macrophages, plays a detrimental role during atherogenesis, leading to the suggestion that autophagy-stimulating approaches may provide benefit. Objective: Dendritic cells (DCs) are at the crossroad of innate and adaptive immune responses and profoundly modulate the development of atherosclerosis. Intriguingly, the role of autophagy in DC function during atherosclerosis and how the autophagy process would impact disease development has not been addressed. Methods and Results: Here, we show that the autophagic flux in atherosclerosis-susceptible Ldlr −/− (low-density lipoprotein receptor–deficient) mice is substantially higher in splenic and aortic DCs compared with macrophages and is further activated under hypercholesterolemic conditions. RNA sequencing and functional studies on selective cell populations reveal that disruption of autophagy through deletion of Atg16l1 differentially affects the biology and functions of DC subsets in Ldlr −/− mice under high-fat diet. Atg16 l1 deficient CD11b + DCs develop a TGF (transforming growth factor)-β–dependent tolerogenic phenotype and promote the expansion of regulatory T cells, whereas no such effects are seen with Atg16l1 deficient CD8α + DCs. Atg16l1 deletion in DCs (all CD11c-expressing cells) expands aortic regulatory T cells in vivo, limits the accumulation of T helper cells type 1, and reduces the development of atherosclerosis in Ldlr −/− mice. In contrast, no such effects are seen when Atg16l1 is deleted selectively in conventional CD8α + DCs and CD103 + DCs. Total T-cell or selective regulatory T-cell depletion abrogates the atheroprotective effect of Atg16l1 deficient DCs. Conclusions: In contrast to its proatherogenic role in macrophages, autophagy disruption in DCs induces a counter-regulatory response that maintains immune homeostasis in Ldlr −/− mice under high-fat diet and limits atherogenesis. Selective modulation of autophagy in DCs could constitute an interesting therapeutic target in atherosclerosis.Keywords
This publication has 41 references indexed in Scilit:
- SLC15A2 and SLC15A4 Mediate the Transport of Bacterially Derived Di/Tripeptides To Enhance the Nucleotide-Binding Oligomerization Domain–Dependent Immune Response in Mouse Bone Marrow–Derived MacrophagesThe Journal of Immunology, 2018
- Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell AnergyCell Reports, 2018
- Deletion of IRF8 (Interferon Regulatory Factor 8)-Dependent Dendritic Cells Abrogates Proatherogenic Adaptive ImmunityCirculation Research, 2018
- Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flowProceedings of the National Academy of Sciences, 2017
- Tregs restrain dendritic cell autophagy to ameliorate autoimmunityJournal of Clinical Investigation, 2017
- Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane trafficThe EMBO Journal, 2016
- Autophagy Links Inflammasomes to Atherosclerotic ProgressionCell Metabolism, 2012
- Macroautophagy Regulates Energy Metabolism during Effector T Cell ActivationThe Journal of Immunology, 2010
- IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These CellsThe Journal of Immunology, 2007
- Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout MiceCirculation, 2003